IceCure Medical Ltd
ICCMNASDAQHealthcare● Active
$3.64
$-0.73(-16.70%)
Market Cap$8197473
P/E Ratio—
52W High$42
52W Low$3.62
IceCure Medical Ltd (ICCM) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ICCM · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
-$1.80
Est. -$0.90 · -100.0%
Revenue
$0.00B
Est. $0.00B · -32.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
ICCM reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 12, 2026 | -$1.50 | — | — | — | $0.00B | — |
| ▼ Q2 FY2026 | May 12, 2026 | -$0.90 | -$1.80 | -100.0% | $0.00B | $0.00B | -32.2% |
| ▼ Q1 FY2026 | Mar 17, 2026 | -$1.20 | -$1.80 | -50.0% | $0.00B | $0.00B | +0.0% |
| ▼ Q4 FY2025 | Nov 19, 2025 | -$0.05 | -$0.06 | -20.0% | $0.00B | $0.00B | +19.1% |
| — Q3 FY2025 | Aug 13, 2025 | -$0.06 | -$0.06 | +0.0% | $0.00B | $0.00B | -20.8% |
| ▲ Q2 FY2025 | May 28, 2025 | -$0.08 | -$0.06 | +25.0% | $0.00B | $0.00B | -3.3% |
| ▼ Q1 FY2025 | Mar 27, 2025 | -$0.07 | -$0.08 | -8.7% | $0.00B | $0.00B | -18.0% |
| ▼ Q4 FY2024 | Nov 26, 2024 | -$0.07 | -$0.08 | -14.3% | $0.00B | $0.00B | -6.6% |
Q3 FY2026
Aug 12, 2026
EPS Actual
—
EPS Est.
-$1.50
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026Miss
EPS Actual
-$1.80
EPS Est.
-$0.90
EPS Surpr.
-100.0%
Revenue
$0.00B
Q1 FY2026
Mar 17, 2026Miss
EPS Actual
-$1.80
EPS Est.
-$1.20
EPS Surpr.
-50.0%
Revenue
$0.00B
Q4 FY2025
Nov 19, 2025Miss
EPS Actual
-$0.06
EPS Est.
-$0.05
EPS Surpr.
-20.0%
Revenue
$0.00B
Q3 FY2025
Aug 13, 2025
EPS Actual
-$0.06
EPS Est.
-$0.06
EPS Surpr.
+0.0%
Revenue
$0.00B
Q2 FY2025
May 28, 2025Beat
EPS Actual
-$0.06
EPS Est.
-$0.08
EPS Surpr.
+25.0%
Revenue
$0.00B
Q1 FY2025
Mar 27, 2025Miss
EPS Actual
-$0.08
EPS Est.
-$0.07
EPS Surpr.
-8.7%
Revenue
$0.00B
Q4 FY2024
Nov 26, 2024Miss
EPS Actual
-$0.08
EPS Est.
-$0.07
EPS Surpr.
-14.3%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-1.92 | $-1.30 | $-0.89 | 1 |
| Q3 FY2026 | $-1.92 | $-1.30 | $-0.89 | 1 |
| Q2 FY2026 | $-2.21 | $-1.50 | $-1.02 | 1 |
| Q1 FY2026 | $-2.07 | $-1.40 | $-0.95 | 1 |
| Q4 FY2025 | $-2.21 | $-1.50 | $-1.02 | 1 |
| Q3 FY2025 | $-2.21 | $-1.50 | $-1.02 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 12, 2026 | -100.0% | $7.20 | $7.20 | +0.00% |
| ▼ Q1 FY2026 | Mar 17, 2026 | -50.0% | $21.90 | $19.95 | -8.90% |
| ▼ Q4 FY2025 | Nov 19, 2025 | -20.0% | $21.68 | $20.99 | -3.18% |
| ▲ Q3 FY2025 | Aug 13, 2025 | +0.0% | $24.60 | $25.20 | +2.44% |
| ▲ Q2 FY2025 | May 28, 2025 | +25.0% | $33.90 | $30.90 | -8.85% |
| ▼ Q1 FY2025 | Mar 27, 2025 | -8.7% | $34.20 | $33.30 | -2.63% |
| ▼ Q4 FY2024 | Nov 26, 2024 | -14.3% | $23.32 | $23.59 | +1.16% |
| ▲ Q3 FY2024 | Aug 20, 2024 | +14.3% | $19.15 | $22.64 | +18.22% |
Q2 FY2026+0.00%
Report Date
May 12, 2026
EPS Beat/Miss
-100.0%
Price Before
$7.20
Price After
$7.20
Q1 FY2026-8.90%
Report Date
Mar 17, 2026
EPS Beat/Miss
-50.0%
Price Before
$21.90
Price After
$19.95
Q4 FY2025-3.18%
Report Date
Nov 19, 2025
EPS Beat/Miss
-20.0%
Price Before
$21.68
Price After
$20.99
Q3 FY2025+2.44%
Report Date
Aug 13, 2025
EPS Beat/Miss
+0.0%
Price Before
$24.60
Price After
$25.20
Q2 FY2025-8.85%
Report Date
May 28, 2025
EPS Beat/Miss
+25.0%
Price Before
$33.90
Price After
$30.90
Q1 FY2025-2.63%
Report Date
Mar 27, 2025
EPS Beat/Miss
-8.7%
Price Before
$34.20
Price After
$33.30
Q4 FY2024+1.16%
Report Date
Nov 26, 2024
EPS Beat/Miss
-14.3%
Price Before
$23.32
Price After
$23.59
Q3 FY2024+18.22%
Report Date
Aug 20, 2024
EPS Beat/Miss
+14.3%
Price Before
$19.15
Price After
$22.64
Avg Beat Reaction+3.94%
Avg Miss Reaction-2.71%
Beat Rate3 / 8 quarters
Largest Move+18.22% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ICCM ends December
IceCure Medical Ltd (ICCM) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $-1.80 — missing the analyst consensus of $-0.90 by -100.0%. The next ICCM earnings date is expected around September 1, 2026.
Each quarter, investors track ICCM earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ICCM revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ICCM's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ICCM earnings · 5 questionsIceCure Medical Ltd's next earnings report is expected around September 1, 2026. ICCM typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ICCM historically reports after market close (AMC).
ICCM earnings datewhen is ICCM earningsICCM next earnings datewhen does ICCM report earningsICCM earnings calendar
▸ Source: FMP · IceCure Medical Ltd SEC filings · US GAAP · IceCure Medical Ltd SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026